CVD Risk in Diabetes: Where Do We Stand and Where Do We Go From Here?
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, September 18, 2008
First Floor Lecture Hall, Forchheimer/AECOM
Ulrich K. Schubart, MD
Professor of Medicine and Molecular Pharmacology
Albert Einstein College of Medicine
Dr. Ulrich K. Schubart graduated from medical school in Berlin and completed his Internal Medicine Residency at Montefiore Medical Center in 1972. He received his basic science as well as clinical endocrinology training at Einstein under Ora Rosen and Norman Fleischer.
After a two-year stay at SUNY at Buffalo, Dr. Schubart joined the Einstein faculty in 1978 and is currently Professor of Medicine and Molecular Pharmacology. He ran his research lab until 2000, when he became Director of the Endocrinology and Diabetes service at JMC.
Dr. Schubart’s basic research focused on the role of protein phosphorylation in the action extracellular signals. He discovered and characterized a highly conserved and widely expressed cytosolic phosphoprotein that controls the polymerization state of microtubules. He generated a knockout mouse that was shown to exhibit decreased fear.
Currently, Dr. Schubart runs a clinical trials unit at Jacobi Medical Center and has been involved in several diabetes trials, including the ongoing NHLBI-sponsored ACCORD trial.
After attending this activity, participants will be able to understand the rationale for implementing current recommendations for diabetes management in patients with high CVD risk.
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.